Research summary, original research, 2011

First-in-human evaluation of a novel robotic-assisted coronary angioplasty system

Granada JF, Delgado JA, Uribe MP, Fernandez A, Blanco G, Leon MB, et al.. JACC. Cardiovascular interventions. 2011

Read the original paper

In plain language

In 8 elective coronary angioplasty patients, a robotic system operated from a remote cockpit worked safely, and the operating physician's measured radiation exposure was 97% lower than at the usual tableside position. Doses to nurses and technologists were not reported.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Interventional cardiologists, Patients
Size
n = 8 patients
Summary based on
the abstract

What it found

  • Operator radiation exposure at the robotic cockpit was far lower than at the standard table position.

    Key figures: 97% lower

  • The primary endpoint of device clinical success without in-hospital major adverse cardiac events was met in all patients.

    Key figures: 100% (8 of 8 patients)

  • The robotic system completed nearly all planned angioplasty steps.

    Key figures: 97.9% (47 of 48 steps)

  • No device- or procedure-related complications and no in-hospital or 30-day major adverse cardiac events occurred.

  • Operators rated robotic performance as equal to or better than manual procedures in almost all cases.

    Key figures: 97.5% of cases

Limits to keep in mind

First-in-human feasibility study of only 8 patients without a randomized manual control group; the abstract does not describe how operator dose was measured, and only the primary operator's exposure was reported, not that of other staff.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.